✦ For YouGeopoliticsTechFinanceHealthEnergySportsCulture
Health & Science

STAT+: A new trick for old science, and biotech VCs’ scrambled playbook

By STAT News · 2026-04-10
STAT+: A new trick for old science, and biotech VCs’ scrambled playbook
CAR-T promise in autoimmunity, GSK's goodbye to leucovorin, and more biotech news

Share this story

𝕏 Twitter in LinkedIn 💬 WhatsApp
More health & science → Read original →

Related stories

CAR-T Surprises Lupus Researchers 5 Years On
CAR-T Surprises Lupus Researchers 5 Years On Health & Science
 STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more
STAT+: Pharmalittle: We’re reading about an FDA delay forcing a biotech to close, a Neurocrine deal, and more Health & Science
 STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more
STAT+: Pharmalittle: We’re reading about FDA seeking new powers over DTC ads, an EU pledge to fight AMR, and more Health & Science
 GSK Discontinues Leucovorin Again
GSK Discontinues Leucovorin Again Health & Science
 CAR T-cell Therapy Cures Woman's Autoimmune Diseases
CAR T-cell Therapy Cures Woman's Autoimmune Diseases Health & Science

Get health & science in your inbox

The best stories, summarized daily. Free.

No spam. Unsubscribe anytime.